Microbix Biosystems Inc.
MBX.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8,345.14% | -97.65% | 89.65% | 79.03% | -35.65% |
| Total Depreciation and Amortization | 7.78% | 4.37% | 6.88% | -14.24% | 4.00% |
| Total Amortization of Deferred Charges | -- | -- | -2.35% | -- | -- |
| Total Other Non-Cash Items | 10.76% | -9.07% | 12.37% | 104.45% | -58.81% |
| Change in Net Operating Assets | -537.54% | 129.67% | -134.31% | -154.93% | 343.79% |
| Cash from Operations | -306.41% | 18.95% | 0.84% | -45.25% | 64.77% |
| Capital Expenditure | 17.67% | -17.78% | 13.78% | 68.54% | -13.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | 17.67% | -17.78% | 13.78% | 77.03% | -54.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 95.68% | -1,571.04% | 0.14% | 75.77% | -312.69% |
| Issuance of Common Stock | -- | 3,338.19% | 1,124.62% | -- | -- |
| Repurchase of Common Stock | 64.17% | -45.57% | -62.32% | -93.73% | 58.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -143.08% | 248.60% | -28.82% | 17.62% | -312.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.64% | 1,616.86% | -46.60% | 341.06% | -170.25% |